, Volume 22, Issue 2, pp 69–72 | Cite as

Endocellular regulation by free radicals and hydrogen peroxide: key determinants of the inflammatory response

  • Luis Vitetta
  • Anthony W. Linnane


The formations of reactive oxygen species (ROS) and reactive nitrogen species (RNS) have long been considered as major contributors to the dysregulation of the inflammatory response. Reactive oxygen species and RNS productions often are reported to be associated with the development of chronic diseases and acceleration of the aging process. Mechanistically, this association has linked the phenomena of oxidative stress with the occurrence of random deleterious modifications of macromolecules with progressive development of pro-inflammatory conditions promoting age-associated systemic diseases. On the contrary the so-called random modification of macromolecules is incorrect rather ROS and RNS are molecular regulators (second messengers) and not universal toxins whose overproduction should be annulled by antioxidants. We have previously reviewed the physiological role of superoxide anion (and hydrogen peroxide) and nitric oxide (and peroxynitrite) and concluded that these reactive molecular species behave as pro-oxidant second messengers. Reactive oxygen species and RNS are produced at specific cellular locations and are essential for both the normal physiological function of the metabolome and the regulated inflammatory response. This brings into question the whole concept of the orally administering of antioxidant molecular species to down-regulate or abrogate an overproduction of free radical activity. There are no human clinical trials that demonstrate that small molecules, the so-called antioxidants (e.g., vitamins C, vitamin E and beta-carotene), confer a favorable clinical outcome of long-lasting control of inflammation.


Inflammation Reactive oxygen species Reactive nitrogen species Free radicals Antioxidants Pro-oxidants Metabolome Protein oxidations 



Luis Vitetta has received National Institute of Complementary Medicine and National Health and Medical Research Council of Australia competitive funding and industry support for research into antioxidants.

Conflict of interest

The authors have no further conflicts of interest relevant to the content of this review.


  1. Bota DA, Van Remmen H, Davies KJ (2002) Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 532(1–2):103–106PubMedCrossRefGoogle Scholar
  2. Bota DA, Ngo JK, Davies KJ (2005) Down regulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radic Biol Med 38(5):665–677PubMedCrossRefGoogle Scholar
  3. Farout L, Friguet B (2006) Proteasome function in aging and oxidative stress: implications in protein maintenance failure. Antioxid Redox Signal 8:205–216PubMedCrossRefGoogle Scholar
  4. Khansari N, Shakiba Y, Mahmoudi M (2009) Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Recent Pat Inflamm Allergy Drug Discov 3(1):73–80PubMedCrossRefGoogle Scholar
  5. Leusen JH, de Klein A, Hilarius PM, Ahlin A, Palmblad J, Smith CI, Diekmann D, Hall A, Verhoeven AJ, Roos D (1996) Disturbed interaction of p21-rac with mutated p67-phox causes chronic granulomatous disease. J Exp Med 184(4):1243–1249PubMedCrossRefGoogle Scholar
  6. Linnane AW, Eastwood H (2006) Cellular redox regulation and prooxidant signaling systems: a new perspective on the free radical theory of aging. Ann N Y Acad Sci 1067:47–55PubMedCrossRefGoogle Scholar
  7. Linnane AW, Kios M, Vitetta L (2007a) Healthy aging: regulation of the metabolome by cellular redox modulation and prooxidant signaling systems: the essential roles of superoxide anion and hydrogen peroxide. Biogerontology 8(5):445–467PubMedCrossRefGoogle Scholar
  8. Linnane AW, Kios M, Vitetta L (2007b) The essential roles of superoxide radical and nitric oxide formation for healthy aging. Mitochondrion 7:1–5PubMedCrossRefGoogle Scholar
  9. Meiners S, Heyken D, Weller A, Ludwig A, Stangl K, Kloetzel PM, Kruger E (2003) Inhibition of proteasome induces concerted expression of proteasome genes and de novo formation of mammalian proteasomes. J Biol Chem 278:21517–21525PubMedCrossRefGoogle Scholar
  10. Singel DJ, Stamler JS (2005) Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrohemoglobin. Ann Rev Physiol 67:99–145CrossRefGoogle Scholar
  11. Stolze IP, Mole DR, Ratcliffe PJ (2006) Regulation of HIF: prolyl hydroxylases. Novartis Found Symp 272:15–25PubMedCrossRefGoogle Scholar
  12. Sun H, Gao J, Ferrington DA, Biesiada H, Williams TD, Squier TC (1999) Repair of oxidized calmodulin by methionine sulfoxide reductase restores ability to activate the plasma membrane Ca-ATPase. Biochemistry 38:105–112PubMedCrossRefGoogle Scholar
  13. Vitetta L, Linnane AW, Gobe GC (2013) From the gastrointestinal tract (GIT) to the kidneys:live bacterial cultures (probiotics) mediating reductions of uremic toxin levels via free radical signaling. Toxins (Basel) 5(11):2042–2057CrossRefGoogle Scholar
  14. Whitehouse MW (1968) Molecular pharmacology of anti-inflammatory drugs: some possible mechanisms of action at the biochemical level. Biochem Pharmacol 17 Suppl 1:293–307Google Scholar
  15. Yin D, Sun H, Weaver RF, Squier TC (1999) Nonessential role for methionines in the productive association between calmodulin and the plasma membrane Ca-ATPase. Biochemistry 38:13654–13660PubMedCrossRefGoogle Scholar
  16. Yin D, Kuczera K, Squier TC (2000) The sensitivity of carboxyl-terminal methionines in calmodulin isoforms to oxidation by H2O2 modulates the ability to activate the plasma membrane Ca-ATPase. Chem Res Toxicol 13:103–110PubMedCrossRefGoogle Scholar

Copyright information

© Springer Basel 2014

Authors and Affiliations

  1. 1.MedlabSydneyAustralia
  2. 2.School of Medicine, The University of QueenslandBrisbaneAustralia

Personalised recommendations